Looking forward to the future, the biotechnology and medical field will be one of the key industries fully supported by countries around the world. In addition to the continuous development of molecular biological automation technology, Litbo also regards "precision inspection" as its own responsibility, and it has continued to invest in the research and development of new instruments and technologies. Taking the global medical market as the blue ocean; taking the market response as the teacher, we are committed to the development of highly competitive full-process automated genetic testing equipment. Through optimizing the operational efficiency, Litbo products not only have a high market share in Taiwan, but also expand the business territory to countries around the world, giving play to LabTurbo's core values!